(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl)methanol, 95.0%, 100mg

N-[3-(Dimethylamino)propyl]acrylamide (stabilized with MEHQ)>98.0%(GC)(T)500g

(2E)-1-(2,5-dimethoxyphenyl)-3-(3-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

(2R,3S,5R)-5-(4-Amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol, 97%, 100mg

2-BROMO-7-METHYL-5H-PYRROLO[2,3-B]PYRAZINE, 95.0%, 1g

Bis(2,4,6-trichlorophenyl) oxalate, 97%, 100g

5-Isopropyl-3-methylisoxazole-4-carboxylic acid, 95.0%, 100mg

(2E)-3-[4-(benzyloxy)phenyl]-1-(3-chlorophenyl)prop-2-en-1-one, 95.0%, 10g

3-Benzoimidazol-1-yl-2-methyl-propionic acid, 95.0%, 1g

5-Bromo-4-fluoro-1-methyl-1H-indazole, 1g

Precision scale Models FX series with internal calibration, dust and water protection according to IP 65, 0.01 g, 2200 g, FZ-2000i-WP

Kryptofix 11 aza, 95.0%, 500g

Methyl 5-Acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-3,5-dideoxy-2-S-phenyl-2-thio-D-glycero-beta-D-galacto-2-nonulopyranosylonate>96.0%(HPLC)200mg